Long Acting
Long Acting Uses, Dosage, Side Effects, Food Interaction and all others data.
Long Acting has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
| Trade Name | Long Acting |
| Generic | Eptacog alfa pegol (activated) |
| Eptacog alfa pegol (activated) Other Names | Activated Recombinant Human Factor VII, Long Acting, Eptacog alfa pegol (activated) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Long Acting
